Sight Sciences, Inc.
SGHT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.7% | 11.7% | -8.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 86.4% | 84.8% | 86.2% | 86.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -34.3% | -53.6% | -72.5% | -54.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -41% | -61% | -80.8% | -62.1% |
| EPS Diluted | -0.16 | -0.23 | -0.28 | -0.23 |
| % Growth | 30.4% | 17.9% | -21.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |